“We welcome the announcement that USTR will initiate an Out-of-Cycle Review of India”: PhRMA
Appreciates continuing efforts by the U.S. Government, including by the Office of USTR to promote compliance with international…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
India remains on USTR Priority Watch List
US trade body announces more in-depth investigation into India's patent laws
WHO’s first global report on antibiotic resistance reveals serious, worldwide threat to public…
The available data reveal that antibiotic resistance is a burgeoning problem in WHO's South-East Asia Region
Court orders temporary halt on Sun Pharma’s $3.2 billion takeover of Ranbaxy
Two individuals filed the petition in the high court of Andhra Pradesh
Hilleman Laboratories’ thermostability technology to help improve coverage of Routine Immunisation…
Quarter of the current birth cohort of 27 million babies in India unimmunised
Brazilian National Sanitary Surveillance Agency certifies Next Breath
Next Breath is now authorised to conduct Pharmaceutical Equivalence studies for Brazil
Johnson & Johnson announces new collaboration to enhance access to anti-TB compound
Will expand reach to more than 130 low and middle-income countries outside of US Johnson & Johnson announced that its…
US FDA approves Zykadia for late-stage lung cancer
Breakthrough therapy drug approved four months ahead of review completion goal date
Glenmark’s novel monoclonal antibody GBR 900 enters human trials
GBR 900 is a first in class monoclonal antibody for the treatment of chronic pain targeting TrkA, the receptor of NGF